Showing 20 of 223 recruiting trials for “acute-promyelocytic-leukemia”
Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia
Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
👨⚕️ Depei Wu, MD. PhD, The First Affiliated Hospital of Soochow University📍 1 site📅 Started Sep 2021View details ↗
SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
RecruitingNCT05014165 ↗
Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
👨⚕️ Adam de Smith, PhD, University of Southern California Keck School of Medicine📍 1 site📅 Started Aug 2021View details ↗
Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
👨⚕️ Liangding Hu, M.D., the Fifth Medical Center the PLA General Hospital📍 1 site📅 Started Jul 2021View details ↗
Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
👨⚕️ Antonio Curti, Istituto di Ematologia Seràgnoli, Azienda Ospedaliero-Universitaria di Bologna (IRCCS)📍 1 site📅 Started Jan 2021View details ↗
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia
👨⚕️ Jianxiang Wang, Dr., Institute of Hematology & Blood Diseases Hospital, China📍 11 sites📅 Started Dec 2020View details ↗
5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
👨⚕️ Benjamin H Tomlinson, Tomlinson, Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center📍 1 site📅 Started Nov 2020View details ↗
A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
RecruitingNCT04290000 ↗
Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →